Hexaware Launches CDAaaS in Partnership with PointCross Life Sciences
Hexaware Technologies and PointCross Life Sciences, have partnered to introduce Clinical Data Automation as a Solution (CDAaaS) powered by PointCross’ Xbiom platform. This solution is designed to enhance the clinical data lifecycle, from collection to submission, for improvements in efficiency and cost-effectiveness.
Key Features of CDAaaS:
- Automated Data Management: CDAaaS leverages the Xbiom platform to automate clinical data management, curation, and standardization, including generation of regulatorily compliant, traceable SDTM, ADaM, and TFLs.
- Advanced Automation: The solution features include metadata repositories (MDR) for automating standards, smart transformers for data curation, indexed repositories with AI augmentation, and onboard biostatistical tools.
- Patient Insights: Onboard visualization and highly configurable dashboards enable ongoing, integrated patient data streams from eCRF and biomarker data from central labs for rapid data QC and assistance to medical monitors in query resolution.
- Cost and Time Efficiency: CDAaaS helps reduce costs and time to view and identify data inconsistencies, relevant findings, exploratory analysis, and EDC and central lab queries for reconciliation.
Hexaware’s reach combined with PointCross’ widely used Xbiom™ technology aims to provide a robust solution for BioPharma and BioTech companies, as well as regulatory agencies tasked with time-bound data review. This collaboration addresses the need for cost reduction and expedited data submission processes in the clinical trials industry.
Srinivas Marimganti, Head of Life Sciences & Healthcare, Hexaware Technologies stated: “We are pleased to partner with PointCross in delivering CDAaaS to our broad range of pharma sponsor customers. This collaboration combines Hexaware’s expertise in clinical solutions with PointCross’ data automation platform, offering a ready-built, deployable solution that aims to enhance data accuracy, compliance, and operational efficiency. We’re excited to bring this capability to the industry, targeted towards driving faster, more reliable outcomes.”
Dr. Suresh Madhavan, CEO, PointCross Inc., added, “By utilizing machine learning and automation, we reduce the cost and time associated with clinical trial data management, while adhering to mandated standards and seamlessly integrating emerging and disparate biomarker data.”
